LANgineers Introduces Elevated Body Temperature Detection Systems for Business

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BURLINGAME, Calif., July 2, 2020 /PRNewswire/ — The CDC “considers a person to have a fever when he or she has a measured temperature of 100.4° F (38° C) or greater.” LANgineers is helping businesses with a safe, fast method to screen all staff and customers entering a business. With their high accuracy thermal imaging cameras, it is not necessary for an employee to risk exposure to infection by standing directly in front of a possibly infected person with a hand-held thermometer.

The LANgineers Elevated Body Temperature Detection System operates at a safe distance (about 10 feet away from subjects) is non-invasive and fast and can discreetly alert staff of anyone entering the building with a relatively high body temperature.

Details about the LANgineers Elevated Body Temperature Detection System:

  • Simultaneous screening, up to 60 persons per minute
  • No operator needed
  • Complete and unobtrusive installation by LANgineers. Portable systems for patrolling inspectors are also available.
  • Variety of alert and notification methods
  • Available accuracy to within 0.3 degrees centigrade
  • Temperature screening, mask detection, stranger alarm, search and report, are among the many features
  • Confirming identity even when the visitor is wearing a mask
  • Fast video search of target people, such as people with abnormal temperatures, without masks, etc…

LANgineers helps protect and support businesses with IP based video security and phone systems.

Contact: Lonnie Domnitz, President
Phone: 650-692-2001 x101
email: 242870@email4pr.com
https://www.langineers.com/

View original content to download multimedia:http://www.prnewswire.com/news-releases/langineers-introduces-elevated-body-temperature-detection-systems-for-business-301087442.html

SOURCE LANgineers, Inc.

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

15 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

15 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

15 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

15 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

15 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

15 hours ago